SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-005797
Filing Date
2017-08-03
Accepted
2017-08-03 12:23:07
Documents
70
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20170630x10q.htm 10-Q 1905778
2 EX-21.1 clvs-20170630ex2111bd900.htm EX-21.1 17214
3 EX-31.1 clvs-20170630ex3115bf7ef.htm EX-31.1 19898
4 EX-31.2 clvs-20170630ex3120382e1.htm EX-31.2 20138
5 EX-32.1 clvs-20170630ex32101b0f8.htm EX-32.1 8006
6 EX-32.2 clvs-20170630ex3222599d6.htm EX-32.2 8387
  Complete submission text file 0001558370-17-005797.txt   6769035

Data Files

Seq Description Document Type Size
7 EX-101.INS clvs-20170630.xml EX-101.INS 1485695
8 EX-101.SCH clvs-20170630.xsd EX-101.SCH 42496
9 EX-101.CAL clvs-20170630_cal.xml EX-101.CAL 62025
10 EX-101.DEF clvs-20170630_def.xml EX-101.DEF 94117
11 EX-101.LAB clvs-20170630_lab.xml EX-101.LAB 422778
12 EX-101.PRE clvs-20170630_pre.xml EX-101.PRE 280097
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 171003975
SIC: 2834 Pharmaceutical Preparations